- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/04 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 213/04
Total number of patents in this class: 239
10-year publication summary
|
18
|
14
|
17
|
25
|
13
|
12
|
22
|
17
|
12
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10338 |
6 |
| Merck Sharp & Dohme Corp. | 2183 |
6 |
| The Johns Hopkins University | 5844 |
6 |
| Nocion Therapeutics, Inc. | 50 |
6 |
| Boehringer Ingelheim International GmbH | 4494 |
5 |
| Gentex Corporation | 1942 |
4 |
| Axonis Therapeutics, Inc. | 17 |
4 |
| The Procter & Gamble Company | 21919 |
3 |
| The Regents of the University of California | 20590 |
3 |
| Canon Inc. | 42633 |
3 |
| Dow AgroSciences LLC | 1194 |
3 |
| Takeda Pharmaceutical Company Limited | 2718 |
3 |
| Vertex Pharmaceuticals Incorporated | 1589 |
3 |
| Purdue Research Foundation | 3874 |
3 |
| The Cleveland Clinic Foundation | 1584 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2645 |
3 |
| Hutchison MediPharma Limited | 106 |
3 |
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
3 |
| Saudi Arabian Oil Company | 13956 |
3 |
| Shenzhen Chipscreen Biosciences Ltd. | 25 |
3 |
| Other owners | 163 |